William Cadden: Risk–Benefit Considerations in Atrial Fibrillation
William Cadden, Director of Medical Device Partnerships at Radcliffe Group, shared a post on LinkedIn:
“At ACC26, Dr Devi G Nair and Dr Vivek Reddy discussed the implications of the late-breaking CHAMPION-AF data, focusing on a central clinical question: how should we weigh stroke risk against bleeding reduction?
The data suggest a modest absolute increase in ischaemic stroke and systemic embolism with a device-based strategy, offset by a substantial reduction in clinically relevant bleeding.
Interpreting this balance is not straightforward and depends on how different endpoints are valued in practice.
A key part of the discussion explored whether all bleeding events should be considered equal, particularly when ‘clinically relevant non-major’ bleeding is included alongside more severe outcomes.
Similarly, the role of procedure-related complications within composite endpoints remains an important consideration when assessing overall benefit.
Ultimately, the conversation reinforces that this is not a one-size-fits-all decision.
The relative importance of stroke prevention versus bleeding avoidance will vary between patients, and careful selection remains essential when considering first-line left atrial appendage closure versus continued anticoagulation.
As longer-term follow-up becomes available, these trade-offs will become clearer and further inform clinical decision-making.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Nov 17, 2026, 10:41Elena Petkovic։ Highlights from the ISBT–WHO Plasma Management Workshop
-
Nov 17, 2026, 10:30Cheng-Hock Toh: Haematology Is Everywhere – But Is It Recognised?
-
Nov 17, 2026, 10:23Akshat Jain: The Importance of Knowing Your Sickle Cell Status
-
Nov 17, 2026, 10:12Caitlin Raymond: What Does Apheresis Really Cost?
-
Nov 17, 2026, 05:47Multidisciplinary Teams Kick Off SAHF MASAC ES 2026 with Pre-Symposium Workshops – South African Haemophilia Foundation
-
Nov 17, 2026, 05:41Boitumelo Malatji: South African Delegation Advances Advocacy Strategies at NNHF Southern Africa Workshop
-
Nov 17, 2026, 05:36Joining the PACTA Uganda Mental Health and Addiction Community Camp 2026 – Tackle Sickle Cell Africa
-
Nov 17, 2026, 05:30Nathan Connell: Women’s Hematology Summit 2027 to Address Hematologic Health Across the Lifespan
-
Nov 17, 2026, 05:25Mane Kurghinyan: Representing Armenia and HemAI Dynamics at the Falling Walls Lab Global Finale 2026